-
Company Insights
Innovation and Patenting activity of Daily Mail & General Trust plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Daily Mail & General Trust plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval Analysis for Anxiety Disorders
Overview How likely is it that the drugs in Anxiety Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anxiety Disorders Overview Anxiety disorders are a group of mental health conditions...
-
Product Insights
NewLikelihood of Approval Analysis for Bipolar Disorder (Manic Depression)
Overview How likely is it that the drugs in Bipolar Disorder (Manic Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar Disorder (Manic Depression) Overview Bipolar disorder, previously known as...
-
Product Insights
NewLikelihood of Approval Analysis for Psychosis
Overview How likely is it that the drugs in Psychosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psychosis Overview Psychosis is a condition that affects the mind and causes a...
-
Product Insights
NewLikelihood of Approval Analysis for Major Depressive Disorder
Overview How likely is it that the drugs in Major Depressive Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Major Depressive Disorder Overview Major Depressive Disorder (MDD) is a common...
-
Product Insights
NewLikelihood of Approval Analysis for Muscle Spasticity
Overview How likely is it that the drugs in Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Muscle Spasticity Overview Muscle spasticity is a condition that causes muscles to...
-
Product Insights
NewLikelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
NewLikelihood of Approval Analysis for Autism Spectrum Disorder (ASD)
Overview How likely is it that the drugs in Autism Spectrum Disorder (ASD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Autism Spectrum Disorder (ASD) Overview Autism Spectrum Disorder (ASD) is...
-
Product Insights
NewLikelihood of Approval Analysis for Back Pain
Overview How likely is it that the drugs in Back Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Back Pain Overview Back pain, a prevalent discomfort, originates from various sources,...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Neuropathic Pain
Overview How likely is it that the drugs in Diabetic Neuropathic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Neuropathic Pain Overview Diabetic neuropathic pain arises from nerve damage...